NEW YORK, July 6 /PRNewswire/ -- On July 3, Denis Corin, Chief Executive Officer of TapImmune, Inc. updated the investment community in an all-new interview with www.wallst.net. Topics covered in the interview include an overview of the company and its growth strategy, recent press releases, market opportunity, and upcoming milestones investors should watch for.
To hear the interview in its entirety, visit http://www.wallst.net, and click on “Interviews.” The interview can be accessed either by locating the company’s ticker symbol under the appropriate exchange on the left-hand column of the “Interviews” section of the site, or by entering the company’s ticker symbol in the Search Archive window.
About TapImmune, Inc.:
TapImmune, Inc. is a biotechnology company specializing in the development of innovative therapeutics and vaccines in the areas of oncology and infectious disease. The company’s lead product, the TAP vaccine, performs a key step in moving characteristic markers called antigens to the surfaces of cells. Without TAP, there are no cancer markers, so the immune system fails to spot the rogue cells and the cancerous cells can grow undetected. The effective restoration of TAP restores and augments antigen presentation and subsequent recognition and killing of cancer cells by the immune system. The TAP molecule also works as an adjuvant or ‘accelerant’ to enhance vaccines against infectious diseases. The company is currently developing AdhTAP for the commencement of toxicology studies leading to the initiation of Phase I clinical trials. The global vaccine market is expected to grow from $13 billion in 2007 to $21 billion in 2010.
For more information about this company, please visit http://www.tapimmune.com.
About WallSt.net:
www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. (http://www.financialmediagroupinc.com). The Web site is a leading provider of timely business news, executive interviews, multimedia content, and research tools. Financial Media Group, Inc. also owns http://www.mywallst.net, a financial social network for investors, and Financial Filings Corp. (http://www.financialfilings.com), a provider of media and compliance solutions to publicly traded companies. In addition to WallSt.net, WallStreet Direct, Inc. owns and operates WallStRadio (http://www.wallstradio.com), a business and finance podcast Web site. We are expecting to receive two hundred eighty dollars from TapImmune, Inc. for the dissemination of this press release. For a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO ) Contact: Nick Iyer 800-4-WALLST
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comWallStreet Direct, Inc.
CONTACT: Nick Iyer, 1-800-4-WALLST, for WallStreet Direct, Inc.
